Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPP-4 Inhibitors and Cognitive Function in T2DM
NCT06164535Phase 4Not yet recruiting
- Sponsor
- Beni Suef University
- Start
- Dec 2023
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Beni Suef University. Primary endpoints: Serum Tumor Necrosis Factor-alpha at 6 months, Mini-Mental State Examination at 6 months and 2 more. Planned start Dec 2023; status: not yet recruiting.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06164535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06164535.